echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Chemicals Industry > Chemical Technology > β-cyclodextrin-polyacrylamide graft compound

    β-cyclodextrin-polyacrylamide graft compound

    • Last Update: 2021-11-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    [Preparation method] Zhou Yuyan et al.


    [Application] Using β-cyclodextrin and polyacrylamide as raw materials, Zhou Yuyan and others synthesized β-cyclodextrin polyacrylamide grafted compounds (β-CD-PAM) through chemical modification, and used 3-cyclodextrin polyacrylamide grafted compounds (β-CD-PAM) respectively.


    When they used β-cyclodextrin polyacrylamide grafted compound and polyacrylamide to treat phenol and aniline simulated wastewater, they found that β-CD-PAM and PAM can absorb aniline in three situations: When the quality of the flocculant and the simulation When the volume ratio of the water sample is less than 0.


     

     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.